Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
3-1 Month Momentum % is the total return of the stock from 3-month ago to 1-month ago. As of today (2026-08-13), Cellebrite DI's 3-1 Month Momentum % is 25.12%.
The industry rank for Cellebrite DI's 3-1 Month Momentum % or its related term are showing as below:
CLBT's 3-1 Month Momentum % is ranked better than 89.08% of 2838
companies
in the Software industry
Industry Median: -6.545
vs CLBT: 25.12
Cellebrite DI (NAS:CLBT) 3-1 Month Momentum % Explanation
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 3-1 Month Momentum % measures the total return to a stock over the past three months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
Cellebrite DI 3-1 Month Momentum % Related Terms
CLBT vs TENB, PAY, BLSH: 3-1 Month Momentum % Comparison
For the Software - Infrastructure subindustry, Cellebrite DI's 3-1 Month Momentum %, along with its competitors' market caps and 3-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cellebrite DI 3-1 Month Momentum % vs Software Industry
For the Software industry and Technology sector, Cellebrite DI's 3-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where Cellebrite DI's 3-1 Month Momentum % falls into.
Cellebrite DI (NAS:CLBT) 3-1 Month Momentum % Calculation
3-1 Month Momentum % is calculated as following:
3-1 Month Momentum %
=
( Price 1-month ago
/
Price 3-month ago
- 1 )
*
100 %
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cellebrite DI (CLBT) has a 3-1 Month Momentum % of 25.12% as of Aug. 13, 2026. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Cellebrite DI and its competitors. According to the industry distribution chart, Cellebrite DI ranks #310 out of 2838 companies in the Software industry, placing it in the top 10.9%.
Is Cellebrite DI's 3-1 Month Momentum % too high?
Cellebrite DI's current 3-1 Month Momentum % is 25.12%. Based on the distribution chart, Cellebrite DI ranks #310 out of 2838 companies in the Software industry, which is in the top quartile — a strong position relative to peers. Overall, Cellebrite DI has a GF Score™ of 82/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Cellebrite DI's 3-1 Month Momentum % compare to TENB and PAY?
According to the Software industry distribution chart, Cellebrite DI ranks #310 out of 2838 companies for 3-1 Month Momentum %. This places Cellebrite DI in the top 11% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-1 Month Momentum % for a Software company?
A good 3-1 Month Momentum % depends on the Software industry context. However, 3-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-1 Month Momentum % mean?
A high 3-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Cellebrite DI and its competitors. Cellebrite DI's current 3-1 Month Momentum % is 25.12%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cellebrite DI stock overvalued right now?
Based on GuruFocus' analysis, Cellebrite DI (CLBT) is currently considered Fairly Valued. The stock's GF Value™ is $16.08, compared to a current price of $15.25 — trading 5.2% below its estimated fair value. The current 3-1 Month Momentum % is 25.12%. Cellebrite DI's overall GF Score™ is 82/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-1 Month Momentum % calculated?
3-1 Month Momentum % is calculated from a company's financial statements. For Cellebrite DI (CLBT), the current 3-1 Month Momentum % is 25.12% as of Aug. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Cellebrite DI (CLBT) Overvalued in 2026?
Based on GuruFocus' analysis, Cellebrite DI stock appears to be undervalued.
The current stock price of $15.25 is trading 5.2% below its estimated GF Value™ of $16.08.
GuruFocus considers Cellebrite DI to be Fairly Valued.
Key valuation signals for CLBT:
3-1 Month Momentum %: 25.12%
GF Value™: $16.08 vs. price of $15.25 (5.2% below fair value)
No single metric tells the full story. See the CLBT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Cellebrite DI Ltd provides AI-powered digital investigative and intelligence solutions that help public and private sector customers transform investigative workflows, make digital data more accessible and actionable, and improve the efficiency of mobile research and application security. Its solutions support law enforcement, defense, and intelligence agencies in advancing investigations, border security, counterterrorism, intelligence operations, and cyber operations. The company's software also enables enterprises and service providers to collect and review data for corporate investigations, eDiscovery, incident response, and mobile application validation. It operates in the Americas, APAC, and EMEA, with the majority of revenue from the Americas.
82GF Score
Get the complete analysis for CLBT
3-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CLBT has been successfully added to your 
